Ernst-Abbe-Zentrum, Ehrenbergstrasse 29, D-98693 Ilmenau, Germany.
Int J Equity Health. 2009 Dec 21;8:44. doi: 10.1186/1475-9276-8-44.
There is an ongoing debate in Germany about the assumption that patients with private health insurance (PHI) benefit from better access to medical care, including shorter waiting times (Lüngen et al. 2008), compared to patients with statutory health insurance (SHI).
Existing analyses of the determinants for waiting times in Germany are a) based on patient self-reports and b) do not cover the inpatient sector. This paper aims to fill both gaps by (i) generating new primary data and (ii) analyzing waiting times in German hospitals.
We requested individual appointments from 485 hospitals within an experimental study design, allowing us to analyze the impact of PHI versus SHI on waiting times (Asplin et al. 2005).
In German acute care hospitals patients with PHI have significantly shorter waiting times than patients with SHI.
Discrimination in waiting times by insurance status does occur in the German acute hospital sector. Since there is very little transparency in treatment quality in Germany, we do not know whether discrimination in waiting times leads to discrimination in the quality of treatment. This is an important issue for future research.
在德国,人们一直在争论一个假设,即拥有私人医疗保险(PHI)的患者相比拥有法定医疗保险(SHI)的患者,在获得医疗服务方面(包括等待时间更短)存在优势(Lüngen 等人,2008 年)。
现有的关于德国等待时间决定因素的分析存在以下两个问题:a)基于患者的自我报告,b)不涵盖住院部门。本文旨在通过(i)生成新的原始数据和(ii)分析德国医院的等待时间,来填补这两个空白。
我们在一项实验研究设计中向 485 家医院提出了预约要求,这使我们能够分析 PHI 与 SHI 对等待时间的影响(Asplin 等人,2005 年)。
在德国急性护理医院,拥有私人医疗保险的患者的等待时间明显短于拥有法定医疗保险的患者。
在德国急性医院部门,确实存在按保险状况划分等待时间的现象。由于在德国,治疗质量几乎没有透明度,我们不知道等待时间的歧视是否会导致治疗质量的歧视。这是未来研究的一个重要问题。